Ali Nowrouzi

Dr. Ali Nowrouzi


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2011 in Viruses
Verified
Journal Article
Open access
PDF file
ANAli Nowrouzi
Ali Nowrouzi
HGHanno Glimm
Hanno Glimm
CKChristof Von Kalle
Christof Von Kalle
MSManfred Schmidt
Manfred Schmidt
The curative potential of retroviral vectors for somatic gene therapy has been demonstrated impressively in several clinical trials leading to sustained long-term correction of the underlying genetic defect. Preclinical studies and clinical monitoring of gene modified hematopoietic stem and progenitor cells in patients have shown that biologically relevant vector induced side effects, ranging from in vitro immortalization to clonal dominance and oncogenesis in vivo, accompany therapeutic efficiency of integrating retroviral gene transfer systems. Most importantly, it has been demonstrated that the genotoxic potential is not identical among all retroviral vector systems designed for clinical application. Large scale viral integration site determination has uncovered significant differences in the target site selection of retrovirus subfamilies influencing the propensity for inducing genetic alterations in the host genome. In this review we will summarize recent insights gained on the mechanisms of insertional mutagenesis based on intrinsic target site selection of different retrovirus families. We will also discuss examples of side effects occurring in ongoing human gene therapy trials and future prospectives in the field.

1 May 2016 in Molecular Therapy
Verified
Journal Article
Open access
TRTim Rath
Tim Rath
SFStefan Fröhling
Stefan Fröhling
CSClaudia Scholl
Claudia Scholl
PCPriya Chudasama
Priya Chudasama
HGHanno Glimm
Hanno Glimm
MSManfred Schmidt
Manfred Schmidt